GSK3β and MCL-1 mediate cardiomyocyte apoptosis in response to high glucose
- 27 Downloads
Gestational diabetes mellitus is a risk factor for congenital heart defects. Our previous results indicated that a decrease in myocardial cells and an increase in apoptotic cells leads to heart defects under hyperglycemia, but much work remains to elucidate this important mechanism of myocardial cell apoptosis induced by high glucose (HG). In this study, we found that a decrease in GSK3β phosphorylation on Ser9 occurred concomitantly with HG-induced cardiomyocyte apoptosis and in the heart tissues of the offspring of diabetic rats in vitro and in vivo. Decreases in GSK3β (Ser9) phosphorylation in response to HG were remarkably restored after treatment with SC79, an activator of the Akt signaling pathway. SB216763, an effective inhibitor of the GSK3β signaling pathway, suppressed HG-induced apoptosis in cardiomyocytes. Further studies showed a decrease in the expression of the anti-apoptotic protein MCL-1 was associated with GSK3β-mediated apoptosis. MCL-1 overexpression partly inhibits HG-induced apoptosis in cardiomyocytes. Herein, this study revealed the roles of GSK3β and MCL-1 in modulating HG-induced cardiomyocyte apoptosis and maternal diabetes-induced abnormalities.
KeywordsCardiomyocyte apoptosis Congenital heart disease High glucose GSK3β MCL-1
We are grateful to everyone who helped complete this research successfully. We especially, thank professor Ma for supporting the research and Lina Guan, who helped us in many experiments.
This research was supported by grants from the National Natural Science Foundation of China (Grant No. 31871391), the Central Public interest Scientific Institution Basal Research Fund (Grant No. 2018GJZ01), and the National Key Research and Development Program of China (Grant No. 2016YFC1000307, YCZYPT ).
Compliance with ethical standards
Conflict of interest
We declare that there are no conflicts of interests.
- Cheng Y, Xia Z, Han Y, Rong J (2016) Plant natural product formononetin protects rat cardiomyocyte H9c2 cells against oxygen glucose deprivation and reoxygenation via Inhibiting ROS formation and promoting GSK-3β phosphorylation. Oxid Med Cell Longev 2016:2060874. https://doi.org/10.1155/2016/2060874 CrossRefGoogle Scholar
- Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol. 7(10):793–803. https://www.ncbi.nlm.nih.gov/pubmed/11033082
- Ding Q, He X, Hsu JM, Xia W, Chen CT, Li LY, Lee DF, Liu JC, Zhong Q, Wang X, Hung MC (2007) Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol Cell Biol 27:4006–4017. https://doi.org/10.1128/MCB.00620-06 CrossRefGoogle Scholar
- Dong M, Hu N, Hua Y, Xu X, Kandadi MR, Guo R, Jiang S, Nair S, Hu D (1832) Ren J (2013) chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress. Biochim Biophys Acta 6:848–863. https://doi.org/10.1016/j.bbadis.2013.02.023 Google Scholar
- Gutierrez JC, Prater MR, Smith BJ, Freeman LE, Mallela MK, Holladay SD (2009) Late-gestation ventricular myocardial reduction in fetuses of hyperglycemic CD1 mice is associated with increased apoptosis. Birth Defects Res B Dev Reprod Toxicol 86(5):409–415. https://doi.org/10.1002/bdrb.20212 CrossRefGoogle Scholar
- Haruki K, Shiba H, Shimada Y, Shirai Y, Iwase R, Fujiwara Y, Uwagawa T, Ohashi T, Yanaga K (2017) Glycogen synthase kinase-3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cells. Ann Gastroenterol Surg 2(1):65–71. https://doi.org/10.1002/ags3.12025 CrossRefGoogle Scholar
- Kabir ME, Singh H, Lu R, Olde B, Leeb-Lundberg LM, Bopassa JC (2015) G protein-coupled estrogen receptor 1 mediates acute estrogen-induced cardioprotection via MEK/ERK/GSK-3β pathway after ischemia/reperfusion. PLoS One 10(9):e0135988. https://doi.org/10.1371/journal.pone.0135988 CrossRefGoogle Scholar
- Thirunavukkarasu M, Selvaraju V, Tapias L, Sanchez JA, Palesty JA, Maulik N (2015) Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway. J Physiol Biochem 71(4):623–633. https://doi.org/10.1007/s13105-015-0426-8 CrossRefGoogle Scholar
- Wertz IE, Kusam S, Lam C, Okamoto T, Sandoval W, Anderson DJ, Helgason E, Ernst JA, Eby M, Liu J, Belmont LD, Kaminker JS, O’Rourke KM et al (2011) Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 471:110–114. https://doi.org/10.1038/nature09779 CrossRefGoogle Scholar
- Wren C, Birrell G, Hawthorne G (2003) Cardiovascular malformations in infants of diabetic mothers, Heart. 89(10): 1217–1220. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1767924/
- Zaouali MA, Panisello A, Lopez A, Castro C, Folch E, Carbonell T, Rolo A, Palmeira CM, Garcia-Gil A, Adam R, Roselló-Catafau J (2017) GSK3β and VDAC involvement in ER stress and apoptosis modulation during orthotopic liver transplantation. Int J Mol Sci 18(3):591. https://doi.org/10.3390/ijms18030591 CrossRefGoogle Scholar